EX-23.1 3 ex23-1.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Form S-1 (File No. 333-283949) and Form S-3 (File No. 333-280244) of our report dated March 31, 2025 with respect to the audited consolidated financial statements of Protagenic Therapeutics, Inc. appearing in this Annual Report on Form 10-K.

/s/ MaloneBailey, LLP

www.malonebailey.com

Houston, Texas

March 31, 2025